Sanofi India appoints Rodolfo Hrosz as new MD

Sanofi India announced that its Board of Directors has appointed Rodolfo Hrosz as the company’s new MD with effect from June 1, 2022, subject to regulatory approvals. He will transition from being Sanofi’s GM, Consumer Healthcare business in Brazil to his new role in India as soon as the applicable regulatory approvals are in place.

A company statement informed that Hrosz joined Sanofi as General Manager of the Consumer Healthcare business in Brazil in 2017 and has led the organisation through several transformative stages, right from the business unit’s inception to it becoming a top growth contributor and a digital-acceleration reference point within the Sanofi Group.

Hrosz brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies. Prior to joining Sanofi, he has worked with Pfizer, LVMH, Heineken and Procter & Gamble in the US and in Brazil.

The company statement said, “With Rodolfo at the helm as Sanofi India’s new Managing Director, the company is geared to mobilise energies, increase agility, and face the new challenges of our industry. His diverse global experiences, particularly in key emerging markets, are assets that will hugely benefit the company’s development.

Aditya Narayan, Chairman of the Board, Sanofi India, “We are delighted to have Rodolfo Hrosz join Sanofi India as its Managing Director and look forward to his leading the team in the further development of the Company. His wide experience and diverse skills make him eminently suitable for this role and we wish him all the very best for every success in his new assignment.”